Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Atlas Genetics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7447
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which is designed for POC testing services to provide accurate solution to screening for the presence of STIs and HAIs. The company’s products and solutions are used in the diagnosis of sexually transmitted infections, neonatal sepsis, and hospital acquired infection. It serves clinicians and other healthcare professionals. The company operates in the US and the UK. Atlas Genetics is headquartered in Trowbridge, the UK.

Atlas Genetics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Atlas Genetics Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Partnerships 14
Atlas Genetics Enters into Agreement with Pharma Company 14
Atlas Genetics Ltd – Key Competitors 15
Atlas Genetics Ltd – Key Employees 16
Atlas Genetics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jan 05, 2018: Life Sciences Pioneer Stanley Lapidus Joins Atlas Genetics Board of Directors 18
Dec 12, 2017: Atlas Genetics Expands Executive Team, Appointing Marc Jones as Chief Operating Officer and Chief Financial Officer 19
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 20
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 21
Legal and Regulatory 22
Oct 08, 2018: Atlas Genetics announces company rebranding, changes name to Binx Health 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Atlas Genetics Ltd, Medical Equipment, Key Facts 2
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Deals By Market, 2012 to YTD 2018 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Atlas Genetics Enters into Agreement with Pharma Company 14
Atlas Genetics Ltd, Key Competitors 15
Atlas Genetics Ltd, Key Employees 16
Atlas Genetics Ltd, Other Locations 17

List of Figures
Atlas Genetics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pentax Europe GmbH-医療機器分野:企業M&A・提携分析
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp is a medical device company that provides clinical endo-imaging solutions. The company offers products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology, and urology. Its products in …
  • Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析
    Amryt Pharma Plc (AMYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Western & Southern Financial Group, Inc.:戦略・SWOT・企業財務分析
    Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Anika Therapeutics Inc (ANIK)-医療機器分野:企業M&A・提携分析
    Summary Anika Therapeutics Inc (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products i …
  • CareDx Inc (CDNA)-医療機器分野:企業M&A・提携分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions for heart transplant patients. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is …
  • lululemon athletica inc.:企業の戦略・SWOT・財務情報
    lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report Summary lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mattel, Inc (MAT):企業の財務・戦略的SWOT分析
    Mattel, Inc (MAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Terumo Corporation:企業のM&A・事業提携・投資動向
    Terumo Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Terumo Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • De La Rue Plc:企業の戦略・SWOT・財務分析
    De La Rue Plc - Strategy, SWOT and Corporate Finance Report Summary De La Rue Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Protagen Protein Services GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that offers protein analytics. The organization offers services such as services for biopharmaceuticals, protein characterization, biosimilars services, and analytic …
  • Crown Point Energy Inc (CWV):企業の財務・戦略的SWOT分析
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • Repsol, S.A.:企業の戦略・SWOT・財務情報
    Repsol, S.A. - Strategy, SWOT and Corporate Finance Report Summary Repsol, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Fossil Group, Inc. (FOSL):企業の財務・戦略的SWOT分析
    Fossil Group, Inc. (FOSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • HOV Services Ltd (HOVS):企業の財務・戦略的SWOT分析
    HOV Services Ltd (HOVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Benitec Biopharma Ltd (BLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Benitec Biopharma Ltd (Benitec) is a clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops ddRNAi based th …
  • InVivo Therapeutics Corp:企業の製品パイプライン分析2018
    Summary InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaf …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • NIKE Inc:企業のM&A・事業提携・投資動向
    NIKE Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIKE Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆